US Demands Transparency Everywhere -- But Only From Everyone Else
from the do-as-I-say,-not-as-I-do dept
Techdirt has written about the Special 301 report many times, but that's not the only US government publication putting other countries on the naughty step. Another is the less well-known National Trade Estimate Report on Foreign Trade Barriers (pdf):
The 2013 National Trade Estimate Report on Foreign Trade Barriers (NTE) is the 28th in an annual series that surveys significant foreign barriers to U.S. exports. This document is a companion piece to the President's Trade Policy Agenda published in March. The issuance of the NTE Report continues the elaboration of an enforcement strategy, utilizing this report, among other tools, in that strategy.
The report offers detailed discussions of the habits of 57 countries, but they all share a rather significant theme: transparency -- or, rather, the lack of it. It really seems the US just can't get enough of it. Here, for example, is a sample of the report's comments from the section on the European Union:
The U.S. pharmaceutical industry has expressed concerns regarding some EU and Member State policies affecting market access for pharmaceutical products, including nontransparent procedures and a lack of meaningful stakeholder input into policies related to pricing and reimbursement, including therapeutic reference pricing and other price controls.
Lack of transparency is also an issue for uranium, it seems:
The United States is concerned that nontransparent EU policies may restrict the import into the EU of enriched uranium, the material from which nuclear power reactor fuel is fabricated.
Public procurement is another area where transparency is cited as a big problem: countries singled out for a mention here include Bulgaria, the Czech Republic, Greece, Hungary, Italy, Lithuania and Slovenia.
Reading through the rest of the 400-page report, it's truly extraordinary to see transparency mentioned dozens of times as one of the US's key concerns with other countries around the world. Of course, that's deeply ironic, since the US was not only the lone holdout against ACTA transparency, and responsible for reducing what little transparency was present in the TPP negotiations, but it even refused to be transparent about its own positions on transparency. Hypocritical much?
Follow me @glynmoody on Twitter or identi.ca, and on Google+
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Filed Under: nte, transparency, ustr
Reader Comments
Subscribe: RSS
View by: Time | Thread
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
cant think of any better advert really. strange how everywhere wants to make sure the USA is a profitable nation at the expense of the rest of the world. quickly been forgotten that the shit pile everywhere is in now was started by the USA! should go down well. i bet most places will be falling over themselves to get off this list though, just like the 301
[ link to this | view in chronology ]
[ link to this | view in chronology ]
I'd say I'm sick of this
What I wouldn't give to see a purge in DC... maybe then we could have some real discussions about what is right for the country (in the best interests of the CITIZENS instead of the lobbyists).
[ link to this | view in chronology ]
Section 1a
The United States Department of Justice ████████ ████ ██ █ ████████ █████ ██ █ ██████████ ██████ █████ ██████ national security ███ ███████ ███████. Related laws██████ ███ ███████ █████ are completely █████ ██ ████████ corrupted. █ ████████ ██████ ███ ██████████!
[ link to this | view in chronology ]
"On enforcement, actions within the EU on the Anti-Counterfeiting Trade Agreement (ACTA) remain a
priority concern for the United States, particularly following the European Parliament’s vote to reject the
Agreement in July 2012, and the Commission’s decision in December 2012 to withdraw its request to the
European Court of Justice to review the Agreement’s consistency with EU law. These actions stand in contrast to the active participation of the Commission and the Member States in the ACTA negotiations,
which concluded in November 2010, and which culminated in the EU and 22 of its Member States signing the ACTA on January 26, 2012."
In other words: "We see what EU did as a result of political obstructionists ignoring the industry requests. What opposition from the people? Only misinformed and extreme elements were opposed to it! What EU parliament, what national parliament? Those are clearly technical trade barriers and thus illegal..."
[ link to this | view in chronology ]
The US government motto, ladies and gentlemen. They are very fond of dictating how every other government how to operate while doing the complete opposite themselves.
Biggest terror organisation in the world = US government
[ link to this | view in chronology ]
Just How Bad?
[ link to this | view in chronology ]
it basically criticises EU member coutnries for daring to demand prices closer to generic medicines where generics exist.
"a generic drug may treat the same disease or symptoms as the innovative
drug in the same therapeutic class, but such drugs may be distinct at the molecular level." AKA, the drugs may be slightly different- WHY, exactly, does this matter? if the drug treats the same disease the same way, then I fail to see why they shouldn't demand similar prices.
[ link to this | view in chronology ]
industry largely supports the reform, with the exception of two provisions: a new industry tax to finance
provision of continuing medical information for doctors and a two - year ban on visits by industry sales
representatives to individual doctors"
I wonder why France might have done those two? ( for the uninformed: the tax is because the information is to prove the medicine's safety, so arguably benefits the manufacturer. the ban on sales representative visits is to curb the practice of practically bribing doctors to prescribe a particular drug.
[ link to this | view in chronology ]